IUCRO-0031; Molecular and Pathological Correlates of Treatment Outcome in Patients with Thymoma and Thymic Carcinoma

Recruiting
18 years - 100 years
All
Phase N/A
1 Location

Brief description of study

The primary objective of this study is to obtain blood and tissue samples for laboratory evaluation.

Detailed description of study

The primary objective of this study is to obtain blood and tissue samples for laboratory evaluation.

Participants will not be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Thymoma and Thymic Carcinoma,Thymoma,Thymic Carcinoma,Thymic Cancer,Thyroid Cancer,Cancer,Oncology,Thyroid
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria
Patient must have documented or suspected thymoma or thymic carcinoma and be able and willing to give written informed consent

Updated on 04 Aug 2024. Study ID: 1011003662 (0212-640)

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team